$ERNA
Eterna Therapeutics Inc.

2022 Q3 Form 10-Q Financial Statement

#000114036122029251 Filed on August 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $3.340M $5.433M $4.514M
YoY Change -21.56% 18.6% 169.81%
% of Gross Profit
Research & Development $4.963M $1.685M $1.782M
YoY Change 238.39% -68.98% 16.24%
% of Gross Profit
Depreciation & Amortization $40.00K $68.00K $36.00K
YoY Change 36.71% 78.01% 42.37%
% of Gross Profit
Operating Expenses $8.304M $13.88M $6.296M
YoY Change 466.19% 38.62% -29.42%
Operating Profit -$8.304M -$13.88M -$6.296M
YoY Change -90.38% 38.62% -29.42%
Interest Expense -$20.00K -$296.0K -$615.0K
YoY Change -1.04%
% of Operating Profit
Other Income/Expense, Net $993.0K $10.48M -$3.079M
YoY Change 258.39% -14658.33% -67.93%
Pretax Income -$7.311M -$3.398M -$9.375M
YoY Change -91.5% -66.31% -49.38%
Income Tax $5.000K $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.300M -$3.400M -$9.400M
YoY Change -91.52% -66.29% -49.25%
Net Earnings / Revenue
Basic Earnings Per Share -$2.49 -$0.06 -$0.17
Diluted Earnings Per Share -$2.49 -$0.06 -$0.17
COMMON SHARES
Basic Shares Outstanding 58.83M 58.81M 53.63K
Diluted Shares Outstanding 2.941M 58.81M 53.63K

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.25M $19.41M $23.50M
YoY Change -45.66% -61.31% 179.43%
Cash & Equivalents $13.25M $19.41M $23.50M
Short-Term Investments
Other Short-Term Assets $1.670M $1.824M $800.0K
YoY Change 23.41% 4.04% 219.69%
Inventory
Prepaid Expenses
Receivables
Other Receivables $926.0K $694.0K
Total Short-Term Assets $15.85M $21.93M $25.14M
YoY Change -38.46% -57.79% 188.46%
LONG-TERM ASSETS
Property, Plant & Equipment $231.0K $424.0K $1.786M
YoY Change -94.52% -27.15% 213.92%
Goodwill $2.000M $2.000M $2.000M
YoY Change -2.14% -2.14% -2.14%
Intangibles
YoY Change
Long-Term Investments $68.00K $89.00K $421.0K
YoY Change -93.2% -82.71% -13.82%
Other Assets $819.0K
YoY Change
Total Long-Term Assets $5.074M $4.977M $10.24M
YoY Change -62.79% -61.02% -14.55%
TOTAL ASSETS
Total Short-Term Assets $15.85M $21.93M $25.14M
Total Long-Term Assets $5.074M $4.977M $10.24M
Total Assets $20.93M $26.90M $35.38M
YoY Change -46.88% -58.43% 70.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.150M $1.478M $1.106M
YoY Change 15.43% -59.83% -38.96%
Accrued Expenses $3.230M $3.821M $2.384M
YoY Change 51.75% 99.41% 105.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $7.467M $7.118M $3.684M
YoY Change 63.73% -7.37% -5.59%
LONG-TERM LIABILITIES
Long-Term Debt $10.00K $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.690M $48.00K $14.38M
YoY Change -92.25% 109.95% 62800.76%
Total Long-Term Liabilities $1.690M $48.00K $14.38M
YoY Change -92.25% 109.95% 62800.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.467M $7.118M $3.684M
Total Long-Term Liabilities $1.690M $48.00K $14.38M
Total Liabilities $12.11M $12.12M $18.07M
YoY Change -54.04% -58.94% -28.08%
SHAREHOLDERS EQUITY
Retained Earnings -$160.8M -$153.5M -$150.1M
YoY Change 6.33% 135.52% 172.5%
Common Stock $15.00K $287.0K
YoY Change -94.24% 28.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.813M $14.78M $17.31M
YoY Change
Total Liabilities & Shareholders Equity $20.93M $26.90M $35.38M
YoY Change -46.88% -58.43% 70.91%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$7.300M -$3.400M -$9.400M
YoY Change -91.52% -66.29% -49.25%
Depreciation, Depletion And Amortization $40.00K $68.00K $36.00K
YoY Change 36.71% 78.01% 42.37%
Cash From Operating Activities -$6.110M -$3.993M -$5.400M
YoY Change -4.87% -41.32% 57.44%
INVESTING ACTIVITIES
Capital Expenditures $50.00K -$187.0K -$46.00K
YoY Change -828.86%
Acquisitions
YoY Change
Other Investing Activities $0.00 $100.0K $0.00
YoY Change -100.0% -21839.13% -100.0%
Cash From Investing Activities -$50.00K -$87.00K -$46.00K
YoY Change -99.78% 18813.04% -117.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.00K -13.00K 11.99M
YoY Change -99.71% -100.03% 20.62%
NET CHANGE
Cash From Operating Activities -6.110M -3.993M -5.400M
Cash From Investing Activities -50.00K -87.00K -46.00K
Cash From Financing Activities 10.00K -13.00K 11.99M
Net Change In Cash -6.150M -4.093M -5.400M
YoY Change -76.15% -109.8% -179.65%
FREE CASH FLOW
Cash From Operating Activities -$6.110M -$3.993M -$5.400M
Capital Expenditures $50.00K -$187.0K -$46.00K
Free Cash Flow -$6.160M -$3.806M -$5.354M
YoY Change -3.99% -44.07% 56.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000748592
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1685000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5432000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3467000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6965000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6205000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4581000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10719000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6204000
CY2022Q2 us-gaap Impairment Of Ongoing Project
ImpairmentOfOngoingProject
5990000
CY2021Q2 us-gaap Impairment Of Ongoing Project
ImpairmentOfOngoingProject
0
us-gaap Impairment Of Ongoing Project
ImpairmentOfOngoingProject
5990000
us-gaap Impairment Of Ongoing Project
ImpairmentOfOngoingProject
0
btx Fees Incurred In Connection With The Common Stock Issued To Lincoln Park
FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark
0
btx Fees Incurred In Connection With The Common Stock Issued To Lincoln Park
FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark
1972000
CY2022Q2 btx Warrant Liabilities Expense
WarrantLiabilitiesExpense
-10792000
CY2021Q2 btx Warrant Liabilities Expense
WarrantLiabilitiesExpense
0
btx Warrant Liabilities Expense
WarrantLiabilitiesExpense
-9470000
btx Warrant Liabilities Expense
WarrantLiabilitiesExpense
0
CY2022Q2 btx Loss On Non Controlling Investment
LossOnNonControllingInvestment
296000
CY2021Q2 btx Loss On Non Controlling Investment
LossOnNonControllingInvestment
0
btx Loss On Non Controlling Investment
LossOnNonControllingInvestment
911000
btx Loss On Non Controlling Investment
LossOnNonControllingInvestment
0
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
17311000
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-5000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
879000
CY2022Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
8000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3398000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
14779000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25503000
btx Stock Issued During Period Value Private Offering
StockIssuedDuringPeriodValuePrivateOffering
0
btx Stock Issued During Period Value Forfeiture Of Unvested Restricted Stock
StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
0
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-5000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2062000
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
8000
us-gaap Net Income Loss
NetIncomeLoss
-12773000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
14779000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
13999000
CY2021Q2 btx Common Stock To Be Retained By Ntn Value Stockholders
CommonStockToBeRetainedByNTNValueStockholders
0
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000
CY2021Q2 btx Stock Issued During Period Value Stock Purchase Agreement
StockIssuedDuringPeriodValueStockPurchaseAgreement
48525000
CY2021Q2 btx Stock Issued During Period Value In Lieu Of Dividends
StockIssuedDuringPeriodValueInLieuOfDividends
0
CY2021Q2 btx Stock Issued During Period Value Forfeiture Of Unvested Restricted Stock
StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
0
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1154000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-10085000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
53603000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
7659000
btx Stock Issued During Period Value Rights Offering Membership Units
StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
10500000
btx Adjustments To Additional Paid In Capital Elimination Historical Member Equity
AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
0
btx Stock Issued During Period Value Acquisitions1
StockIssuedDuringPeriodValueAcquisitions1
8178000
btx Stock Issued During Period Value New Issues Of Preferred Stock Retained By Stockholders
StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
0
us-gaap Partners Capital Account Acquisitions
PartnersCapitalAccountAcquisitions
0
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
5765000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000
btx Stock Issued During Period Value Stock Purchase Agreement
StockIssuedDuringPeriodValueStockPurchaseAgreement
48525000
btx Stock Issued During Period Value In Lieu Of Dividends
StockIssuedDuringPeriodValueInLieuOfDividends
0
btx Stock Issued During Period Value Forfeiture Of Unvested Restricted Stock
StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
0
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1573000
us-gaap Net Income Loss
NetIncomeLoss
-28607000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
53603000
btx Proceeds From Issuance Of Common Stock To Lincoln Park
ProceedsFromIssuanceOfCommonStockToLincolnPark
0
btx Proceeds From Issuance Of Common Stock To Lincoln Park
ProceedsFromIssuanceOfCommonStockToLincolnPark
50497000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
299000
btx Initial Measurement Of Right Of Use Assets And Liabilities
InitialMeasurementOfRightOfUseAssetsAndLiabilities
1706000
btx Initial Measurement Of Right Of Use Assets And Liabilities
InitialMeasurementOfRightOfUseAssetsAndLiabilities
874000
CY2022Q2 us-gaap Cash
Cash
19400000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-153500000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3400000
us-gaap Net Income Loss
NetIncomeLoss
-12800000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9400000
CY2021Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
12600000
CY2022Q2 btx Over Subscription Amount Received
OverSubscriptionAmountReceived
600000
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
12000000.0
CY2022Q2 btx Over Subscription Amount Received
OverSubscriptionAmountReceived
600000
btx Write Off Of Operating Lease Liability
WriteOffOfOperatingLeaseLiability
1453000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2823000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
673000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
688000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2433000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
390000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1943000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2723000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
12589000
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
-10065000
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2524000
CY2022Q2 btx Operating Lease Area
OperatingLeaseArea
5200
CY2022Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P62M
btx Base Rent Per Square Foot
BaseRentPerSquareFoot
6.35
CY2022Q2 btx Percentage Base Rent Increase On Each Anniversary
PercentageBaseRentIncreaseOnEachAnniversary
0.03
CY2022Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
btx Initial Measurement Of Operating Lease Rou Assets
InitialMeasurementOfOperatingLeaseROUAssets
1700000
btx Initial Measurement Of Operating Lease Liabilities
InitialMeasurementOfOperatingLeaseLiabilities
1700000
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
800000
CY2022Q1 btx Lessee Commitment To Purchase Property
LesseeCommitmentToPurchaseProperty
50000
CY2022Q1 btx Unamortized Leasehold Improvements
UnamortizedLeaseholdImprovements
50000
CY2022Q1 us-gaap Deposit Assets
DepositAssets
63000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
146000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
164000
CY2022Q2 us-gaap Sublease Income
SubleaseIncome
21000
CY2021Q2 us-gaap Sublease Income
SubleaseIncome
21000
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
51000
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
1000
CY2022Q2 us-gaap Lease Cost
LeaseCost
176000
CY2021Q2 us-gaap Lease Cost
LeaseCost
144000
us-gaap Operating Lease Cost
OperatingLeaseCost
333000
us-gaap Operating Lease Cost
OperatingLeaseCost
315000
us-gaap Sublease Income
SubleaseIncome
42000
us-gaap Sublease Income
SubleaseIncome
42000
us-gaap Variable Lease Cost
VariableLeaseCost
53000
us-gaap Variable Lease Cost
VariableLeaseCost
10000
us-gaap Lease Cost
LeaseCost
344000
us-gaap Lease Cost
LeaseCost
283000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2567000
btx Initial Measurement Of Operating Lease Rou Assets
InitialMeasurementOfOperatingLeaseROUAssets
1706000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
186000
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
772000
btx Write Off Of Operating Lease Right Of Use Asset
WriteOffOfOperatingLeaseRightOfUseAsset
1372000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y2M12D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0897
btx Initial Measurement Of Operating Lease Liabilities
InitialMeasurementOfOperatingLeaseLiabilities
1706000
btx Principal Payments On Operating Lease Liabilities
PrincipalPaymentsOnOperatingLeaseLiabilities
153000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
703000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
708000
CY2022Q2 btx Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
470000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3541000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
718000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2823000
CY2018Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
6000000.0
CY2022Q2 us-gaap Goodwill
Goodwill
2000000.0
us-gaap Impairment Of Ongoing Project
ImpairmentOfOngoingProject
6000000.0
CY2022Q2 us-gaap Impairment Of Ongoing Project
ImpairmentOfOngoingProject
6000000.0
CY2022Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0
CY2022Q1 us-gaap Share Price
SharePrice
2.05
CY2022Q2 us-gaap Share Price
SharePrice
0.52
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1613000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
656000
CY2022Q2 btx Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
388000
CY2021Q4 btx Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
222000
CY2022Q2 btx Accrued General And Administrative Expenses
AccruedGeneralAndAdministrativeExpenses
1820000
CY2021Q4 btx Accrued General And Administrative Expenses
AccruedGeneralAndAdministrativeExpenses
371000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3821000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1249000
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1200000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
879000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1154000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2062000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1573000
CY2021Q1 btx Stock Issued During Period Shares Acquisitions1
StockIssuedDuringPeriodSharesAcquisitions1
1068000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11244000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11244000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3513000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3513000
CY2022Q2 us-gaap Deposit Assets
DepositAssets
477000
CY2021Q4 us-gaap Deposit Assets
DepositAssets
488000
btx Gain Loss On Disposal Of Fixed Assets
GainLossOnDisposalOfFixedAssets
274000
btx Gain Loss On Disposal Of Fixed Assets
GainLossOnDisposalOfFixedAssets
0
btx Gain On Termination Of Lease
GainOnTerminationOfLease
85000
btx Gain On Termination Of Lease
GainOnTerminationOfLease
0
btx Warrant Liabilities Expense
WarrantLiabilitiesExpense
-9470000
btx Warrant Liabilities Expense
WarrantLiabilitiesExpense
0
btx Loss On Non Controlling Investment
LossOnNonControllingInvestment
911000
btx Loss On Non Controlling Investment
LossOnNonControllingInvestment
0
btx Increase Decrease In Deposit Assets And Other Non Current Assets
IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets
-11000
btx Increase Decrease In Deposit Assets And Other Non Current Assets
IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets
27000
btx Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-153000
btx Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-139000
btx Payments Of Paycheck Protection Program Loan
PaymentsOfPaycheckProtectionProgramLoan
0
btx Payments Of Paycheck Protection Program Loan
PaymentsOfPaycheckProtectionProgramLoan
532000
btx Noncash Or Part Noncash Acquisition Preferred Shares Issued In Connection With Reverse Merger
NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger
0
btx Noncash Or Part Noncash Acquisition Preferred Shares Issued In Connection With Reverse Merger
NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger
1000

Files In Submission

Name View Source Status
0001140361-22-029251-index-headers.html Edgar Link pending
0001140361-22-029251-index.html Edgar Link pending
0001140361-22-029251.txt Edgar Link pending
0001140361-22-029251-xbrl.zip Edgar Link pending
brhc10040603_10q.htm Edgar Link pending
brhc10040603_ex10-3.htm Edgar Link pending
brhc10040603_ex31-1.htm Edgar Link pending
brhc10040603_ex31-2.htm Edgar Link pending
brhc10040603_ex32-1.htm Edgar Link pending
brhc10040603_10q_htm.xml Edgar Link completed
brhc10040603_ex32-2.htm Edgar Link pending
btx-20220630.xsd Edgar Link pending
ex10_3image00001.jpg Edgar Link pending
ex10_3image00002.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
logo01.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
btx-20220630_cal.xml Edgar Link unprocessable
btx-20220630_lab.xml Edgar Link unprocessable
btx-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
btx-20220630_def.xml Edgar Link unprocessable